Atlas Trials

A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients

Clinical trial NCT04377711 · COMPLETED

Trial details

NCT number
NCT04377711
Sponsor
Covis Pharma S.à.r.l.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2020-06-08
Primary completion
2021-01-05
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.